The latest international news, analysis and features on the HIV epidemic from Avert. Share your views and expertise with your peers in the comments box below the articles.
A study suggests vaginal bacteria may be playing an underestimated role in PrEP efficacy for women
National data from five Southern African countries suggests nearly 89% of adults on HIV treatment are virally suppressed – but gaps remain.
Malawians in some rural areas face travel times to HIV clinics that are almost double others’ journeys.
Evidence review suggests enhanced testing services, which offer things such as counselling or support groups, are having little impact on condom use.
UChoose study is the first to assesses adolescent girls’ preferences for contraceptives that mirror PrEP products to establish what type of PrEP is most likely to work for them
News the HIV world has been waiting for – long-acting injectable cabotegravir (CAB-LA) is a potentially game-changing tool to prevent HIV in women.
Test and treat analysis from Eastern Uganda finds 90% of people diagnosed start treatment – but one in five has left care after 12 months
Gay men and transgender women who have sex with men in Nairobi and Johannesburg are active social media users, possibly providing an untapped opportunity for sexual health promotion on these platforms.
User fees lead to a ‘drastic’ fall in the number of people starting HIV care at a PEPFAR-funded clinic in Lagos.
Rates of viral suppression among men significantly increase – and approach that of women – when services are provided in the community instead of in-clinic.